AGEN
Price
$3.04
Change
+$0.09 (+3.05%)
Updated
May 8 closing price
Capitalization
82.6M
AMLX
Price
$4.58
Change
-$0.29 (-5.95%)
Updated
May 8 closing price
Capitalization
433.84M
90 days until earnings call
Ad is loading...

AGEN vs AMLX

Header iconAGEN vs AMLX Comparison
Open Charts AGEN vs AMLXBanner chart's image
Agenus
Price$3.04
Change+$0.09 (+3.05%)
Volume$475.87K
Capitalization82.6M
Amylyx Pharmaceuticals
Price$4.58
Change-$0.29 (-5.95%)
Volume$2.09M
Capitalization433.84M
AGEN vs AMLX Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. AMLX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Hold and AMLX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (AGEN: $3.04 vs. AMLX: $4.58)
Brand notoriety: AGEN and AMLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 76% vs. AMLX: 228%
Market capitalization -- AGEN: $82.6M vs. AMLX: $433.84M
AGEN [@Biotechnology] is valued at $82.6M. AMLX’s [@Biotechnology] market capitalization is $433.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileAMLX’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • AMLX’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while AMLX’s TA Score has 5 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • AMLX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а +6.29% price change this week, while AMLX (@Biotechnology) price change was -10.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

AGEN is expected to report earnings on Mar 17, 2025.

AMLX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($434M) has a higher market cap than AGEN($82.6M). AMLX has higher P/E ratio than AGEN: AMLX (2.69) vs AGEN (0.46). AMLX YTD gains are higher at: 21.164 vs. AGEN (10.949). AGEN has higher annual earnings (EBITDA): -77.64M vs. AMLX (-290.98M). AMLX has more cash in the bank: 177M vs. AGEN (44.8M). AMLX has less debt than AGEN: AMLX (1.98M) vs AGEN (78.4M). AGEN has higher revenues than AMLX: AGEN (160M) vs AMLX (87.4M).
AGENAMLXAGEN / AMLX
Capitalization82.6M434M19%
EBITDA-77.64M-290.98M27%
Gain YTD10.94921.16452%
P/E Ratio0.462.6917%
Revenue160M87.4M183%
Total Cash44.8M177M25%
Total Debt78.4M1.98M3,958%
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGENAMLX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLYPX30.410.12
+0.40%
American Beacon Man Lg Cp Growth Inv
SFILX13.94N/A
N/A
Schwab Fundamental Intl Sm Eq Idx
NBSRX47.85N/A
N/A
Neuberger Berman Sustainable Equity Inv
FUFRX24.14N/A
N/A
Franklin Utilities R6
EMQCX7.90N/A
N/A
Ashmore Emerging Markets Active Eq C